Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H16O8 |
InChIKeyBQPYWEBQTWYRLD-UHFFFAOYSA-N |
CAS Registry2832051-00-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | IT | 01 Feb 2023 |